Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Clinical Ophthalmology (Auckland, N.Z.)|December 10, 2020
Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)Elisabeth Van Aken, Mérédis Favreau, Eva Ramboer, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 26, 2020
Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUS<sup>TM</sup> StudyAnita M Leys, Eva Ramboer, Mérédis Favreau, et al.
Expert Opinion on Biological Therapy|February 13, 2018
Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of 'real-world' evidenceJonathan A Bernstein, Abhishek Kavati, Michael D Tharp, et al.
Journal of Medical Economics|August 22, 2019
Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphomaAli McBride, Andriy Krendyukov, Nicola Mathieson, et al.
Journal of the Advanced Practitioner in Oncology|February 2, 2023
Meta-Analysis of Same-Day Pegfilgrastim Administration Stratified by Myelotoxic Febrile Neutropenia Risk and Tumor TypeNeda Alrawashdh, Ali McBride, Mok Oh, et al.
Archives of Cardiovascular Diseases|April 16, 2013
Modelling of blood pressure outcomes in patients with and without established cardiovascular or renal disease following treatment with valsartan (the PREVIEW study)Karen Macdonald, Heidi Brié, Stefaan Vancayzeele, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2009
Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) studyHeinz Ludwig, Matti Aapro, Carsten Bokemeyer, et al.
Journal of Geriatric Oncology|September 28, 2013
Modeling of treatment response to erythropoiesis-stimulating agents in older (age≥70years) and younger (age<70years) patients with cancer and anemia: findings from the Anemia Cancer Treatment studyIvo Abraham, Karen MacDonald, Soba Tharmarajah, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 12, 2009
Promoting evidence-based management of anemia in cancer patients: concurrent and discriminant validity of RESPOND, a web-based clinical guidance system based on the EORTC guidelines for supportive care in cancerJoanna Van Erps, Matti Aapro, Karen MacDonald, et al.
Leukemia Research|November 4, 2021
No margin for non-adherence: Probabilistic kaplan-meier modeling of imatinib non-adherence and treatment response in CML (ADAGIO study)Mavis Obeng-Kusi, Karen MacDonald, Marie-Anne van Lierde, et al.
Pageof 9